The name is absent

Grace, A. A., 2002. Dopamine. In: Davis, K. L., Charney, D., Coyle, J. T., Nemeroff, C., (Eds),
Neuropsychopharmacolgy: The Fifth Generation of Progress. Lippincott, Williams, and
Wilkins, Philadelphia, PA, pp. 119-132.

Gruss, M., Braun, K., 2004. Age- and region-specific imbalances of basal amino acids and
monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem.
Int. 45, 81-88.

Hayashi, M. L., Rao, B. S., Seo, J. S., Choi, H. S., Dolan, B. M., Choi, S. Y., Chattarji, S.,
Tonegawa, S., 2007. Inhibition of p21-activated kinase rescues symptoms of fragile X
syndrome in mice. Proc. Natl. Acad. Sci. U. S. A. 104, 11489-11494.

Hinton, V. J., Brown, W. T., Wisniewski, K., Rudelli, R. D., 1991. Analysis of neocortex in three
males with the fragile X syndrome. Am. J. Med. Genet. 41, 289-294.

Kimball, S. R., 1999. Eukaryotic initiation factor eIF2. Int. J. Biochem. Cell Biol. 31, 25-29.

Meeker, D., Kim, J. H., Vezina, P., 1998. Depletion of dopamine in the nucleus accumbens
prevents the generation of locomotion by metabotropic glutamate receptor activation.
Brain Res. 812, 260-264.

Pintor, A., Potenza, R. L., Domenici, M. R., Tiburzi, F., Reggio, R., Pezzola, A., Popoli, P.,
2000. Age-related decline in the functional response of striatal group I mGlu receptors.
Neuroreport 11, 3033-3038.

Quevedo, C., Alcazar, A., Salinas, M., 2000. Two different signal transduction pathways are
implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-
stimulated neuronal cells. J. Biol. Chem. 275, 19192-19197.

<<   2   3   4   5   6   7   8   >>

More intriguing information